Navigation Links
Neurocrine Biosciences Presents Elagolix Data
Date:6/16/2009

osis suffer from both efficacy and safety shortcomings. The current standards of care such as contraceptives and analgesics (non-steroidal anti-inflammatory drugs) are often ineffective in controlling the symptoms of endometriosis. Likewise, while peptide gonadotropin-releasing hormone (GnRH) agonists such as Lupron(R) (leuprolide acetate) and Zoladex(R) (goserelin acetate) are highly effective in controlling symptoms of endometriosis, these products cause an initial, transient heightening in symptom severity, as well as hot flashes throughout the course of therapy. Most importantly, because all GnRH agonists suppress estrogen to very low levels, long-term treatment is not possible due to the severe bone loss that occurs in patients.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine related diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's GnRH pr
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
2. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Reports First Quarter 2008 Results
5. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
6. SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production
7. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
8. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
9. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
10. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
11. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Dynatronics Corporation (NASDAQ: DYNT ) today ... to the Company,s Board of Directors effective March 23, 2015, ... 2014 of board member Joseph Barton .  ... Board of Directors represents an important step forward for the ... of Dynatronics.  "Rich is a proven leader and is well-known ...
(Date:3/27/2015)... TEMPLE, Texas , March 27, 2015 The ... relocate in April to a 5,000-square-foot building at 1802 South ... a geographic area designated by the City of ... Baylor Scott & White and the Central Texas Veterans Health ... office and laboratory space to early stage biotechnology and life ...
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... Jan. 15 The overall survival rate from,cancer now ... cancer than,in younger children, in part because of a ... age group, according to a study by pediatric,oncologists at ... rates in children younger than 15 with cancer have,improved ...
... 15 Tolerx, Inc., a,biopharmaceutical company engaged in ... treatment of immune-mediated diseases, announced today,the successful completion ... a novel,humanized anti-CD4 monoclonal antibody (MAb), in subjects ... study was designed to,assess the safety, tolerability, and ...
Cached Medicine Technology:Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients 2Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients 3Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus 2Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus 3
(Date:3/29/2015)... Aliso Viejo, California (PRWEB) March 29, 2015 ... have revealed a new transition from Pixel Film Studios, ... 12 sports transitions made exclusively for Final Cut Pro ... “We’ve given our users the tools needed to effortlessly ... Film Studios introduces TranSports, a new and uniquely styled ...
(Date:3/28/2015)... Coffee could not only perk you up in the ... researchers have found. , They found that those who drank ... Antioxidants fight gum disease. Does coffee, then, help fight gum ... M. Goldman School of Dental Medicine explored in a ... Journal of Periodontology. , “This is the first long-term study ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 With ... in the fields of osteoporosis, osteoarthritis and musculoskeletal ... Osteoporosis, it may be the first time in ... research forum that the hot-button topic is an ... on the well-accepted scientific principles of Wolff’s law, ...
(Date:3/28/2015)... Orlando, FL (PRWEB) March 28, 2015 ... pre-existing conditions coverage is made available to all visitors ... States, effective immediately. All members are encouraged to purchase ... finalized to avoid lack of proper coverage for pre-existing ... suffer from one or two medical conditions with serious ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 One ... re-injury, according to research presented today at the American ... Day. The study examined the long term success of ... , “We examined survey data from 242 patients who ... author Justin P. Roe, MBBS, FRACS, from North Sydney ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... need to modernize government efforts , , THURSDAY, April 9 ... years, the incidence of many foodborne illnesses in the ... officials announced Thursday. , "Progress has plateaued," Dr. Robert ... and Mycotic Diseases at the U.S. Centers for Disease ...
... Chinese Raw Materials Testing Program Was Featured in ... Chondroitin from Shandong Zhongyuan Greentech Co., Ltd., ... tested for purity by the Natural Products Association,s ... results of those tests are now available to ...
... union elections in New England history, workers unite for ... April 9 Healthcare workers at St. Elizabeth,s ... Christi Health Care chain, today announced they have voted ... hospital-wide vote. The vote means more than 850 St. ...
... new procedure for regenerating damaged articular cartilage in the ... Rush is the only center in Illinois participating in ... called the Cartilage Autograft Implantation System (CAIS), involves extracting ... knee, breaking it into tiny fragments to enable it ...
... and Health Care Safety NetNAPERVILLE, Ill., April 9 ... and national economic crisis, according to a survey conducted ... that hospitals, many of which were already struggling before ... and significant financial challenges, with patients being affected as ...
... to Expand Participation and Donations , NEW YORK, April ... community will unite in New York City,s Central Park ... awareness and funds for Parkinson,s disease research. The two-mile ... this community to come together to celebrate and recognize ...
Cached Medicine News:Health News:Declines in Foodborne Illness Have Plateaued, Report Says 2Health News:Natural Products Association Announces Chondroitin Testing Results For Greentech 2Health News:Nearly 900 Workers at Caritas St. Elizabeth's Medical Center Make History With Vote to Join 1199SEIU 2Health News:Nearly 900 Workers at Caritas St. Elizabeth's Medical Center Make History With Vote to Join 1199SEIU 3Health News:Study assesses new surgical procedure for regenerating cartilage in damaged knee joints 2Health News:Illinois Hospitals Hit Hard By Recession 2Health News:Illinois Hospitals Hit Hard By Recession 3Health News:Parkinson's Disease Community Unites to Find a Cure at the 15th Annual Parkinson's Unity Walk 2Health News:Parkinson's Disease Community Unites to Find a Cure at the 15th Annual Parkinson's Unity Walk 3
... support and stabilization for non-operable hip disorders ... hip arthroplasty. Neoprene padding is secured to ... interface. This brace may be ordered with ... joints. , ,POSTERIOR PANEL: The ...
... Abduction Orthosis provides stabilization for patients prone ... hip revision, for anterior or posterior hip ... spastic, tight adductors secondary to hemiplegia or ... Orthosis features flexion/extension ROM control from 0° ...
... is the solution to the difficult problem ... fits like a custom and can be ... Bledsoe Simple Pelvic Brace limits hip flexion/ ... in 15 increments from -30 to 105 ...
... Triplanar hip joint is adjustable ... extension, abduction - Ad-duction, and ... Boston Post-Op Hip Orthosis. ... Hip Spicas in both adult ...
Medicine Products: